Risperidone (CAS 106266-06-2) — formula C23H27FN4O2, molecular weight 410.5.
| CAS Number | 106266-06-2 |
|---|---|
| Molecular Formula | C23H27FN4O2 |
| Molecular Weight | 410.5 |
| Melting Point | 170 |
| Boiling Point | 442 |
| LogP | 2.86 |
| Applications | Uses: Antipsychotic Agents, Dopamine Antagonists, Serotonin Antagonists, MEDICATION, Use (kg, approx.) in Germany (2009): >100, Use (kg) in USA (2002): 458, Consumption (g per capita, approx.) in Germany (2009): 0.00122, Consumption (g per capita) in the USA (2002): 0.00162, Calculated removal (%): 12.8, For the treatment of schizophrenia in adults and in adolescents, ages 13 to 17, and for the short-term treatment of manic or mixed episodes of bipolar I disorder in children and adolescents ages 10 to 17. May also be used to manage symptoms of inappropriate behavior due to aggression and, or psychosis in patients with severe dementia., Use Classification: Pharmaceuticals, Methods of Manufacturing: A Friedel-Crafts condensation of 1-acetylpiperidone-4-carbonyl chloride and 2, 4-difluorobenzene, followed by hydrolysis of the N-acetyl group yields 4-(2, 4-difluorobenzoyl)piperidone and the benzoyl carbonyl is converted to the oxime. With alkali, the fluorine atom in the 2-position is displaced through ring closure to form the isoxazole moiety. The secondary amine of the piperidine ring is alkylated with 3-(2-chloroethyl)pyridol[1, 2-a]pyrimidin-4-one to yield the product., Preparation: L. E. J. Kennis, J. Vandenberk, European Patent Office 196132, eidem, United States of America patent 4804663 (1986, 1989 both to Janssen), Impurities: 3-[2-[4-[(E)-(2, 4-difluorophenyl)(hydroxyimino)methyl]piperidin-1-yl]ethyl]-2-methyl-6, 7, 8, 9-tetrahydro-4H-pyrido[1, 2-a]pyrimidin-4-one, 3-[2-[4-[(Z)-(2, (9RS)-3-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6, 3-[2-[4-(5-fluoro-1, 2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6, (6RS)-3-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2, 6-dimethyl-6, 2-[2-methyl-4-oxo-6, 2-a]pyrimidin-3-yl]ethyl 4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperidine-1-carboxylate, 3-[2-[4-(2, 4-difluorobenzoyl)piperidin-1-yl]ethyl]-2-methyl-6, 3-[2-[4-[4-fluoro-2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperidine-1-yl]benzoyl]piperidin-1-yl]ethyl]-2-methyl-6, Formulations, Preparations: Table: Risperidone Preparations [Table#7275], Table: Risperidone Preparations [Table#7276] |
Documented applications: Uses: Antipsychotic Agents, Dopamine Antagonists, Serotonin Antagonists, MEDICATION, Use (kg, approx.) in Germany (2009): >100, Use (kg) in USA (2002): 458, Consumption (g per capita, approx.) in Germany (2009): 0.00122, Consumption (g per capita) in the USA (2002): 0.00162, Calculated removal (%): 12.8, For the treatment of schizophrenia in adults and in adolescents, ages 13 to 17, and for the short-term treatment of manic or mixed episodes of bipolar I disorder in children and adolescents ages 10 to 17. May also be used to manage symptoms of inappropriate behavior due to aggression and, or psychosis in patients with severe dementia., Use Classification: Pharmaceuticals, Methods of Manufacturing: A Friedel-Crafts condensation of 1-acetylpiperidone-4-carbonyl chloride and 2, 4-difluorobenzene, followed by hydrolysis of the N-acetyl group yields 4-(2, 4-difluorobenzoyl)piperidone and the benzoyl carbonyl is converted to the oxime. With alkali, the fluorine atom in the 2-position is displaced through ring closure to form the isoxazole moiety. The secondary amine of the piperidine ring is alkylated with 3-(2-chloroethyl)pyridol[1, 2-a]pyrimidin-4-one to yield the product., Preparation: L. E. J. Kennis, J. Vandenberk, European Patent Office 196132, eidem, United States of America patent 4804663 (1986, 1989 both to Janssen), Impurities: 3-[2-[4-[(E)-(2, 4-difluorophenyl)(hydroxyimino)methyl]piperidin-1-yl]ethyl]-2-methyl-6, 7, 8, 9-tetrahydro-4H-pyrido[1, 2-a]pyrimidin-4-one, 3-[2-[4-[(Z)-(2, (9RS)-3-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6, 3-[2-[4-(5-fluoro-1, 2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6, (6RS)-3-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2, 6-dimethyl-6, 2-[2-methyl-4-oxo-6, 2-a]pyrimidin-3-yl]ethyl 4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperidine-1-carboxylate, 3-[2-[4-(2, 4-difluorobenzoyl)piperidin-1-yl]ethyl]-2-methyl-6, 3-[2-[4-[4-fluoro-2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperidine-1-yl]benzoyl]piperidin-1-yl]ethyl]-2-methyl-6, Formulations, Preparations: Table: Risperidone Preparations [Table#7275], Table: Risperidone Preparations [Table#7276].
Risperidone is a chemical compound with CAS registry number 106266-06-2 and molecular formula C23H27FN4O2 (molecular weight 410.5).
CAS number: 106266-06-2
Its molecular formula C23H27FN4O2 comprises 23 C, 27 H, 1 F, 4 N, 2 O atoms.
Also known as: Risperidone · 利培酮
The CAS registry number of Risperidone is 106266-06-2.
Molecular formula C23H27FN4O2, molecular weight 410.5.
It is also registered under: Risperidone, 利培酮.
Recorded applications: Uses: Antipsychotic Agents, Dopamine Antagonists, Serotonin Antagonists, MEDICATION, Use (kg, approx.) in Germany (2009): >100, Use (kg) in USA (2002): 458, Consumption (g per capita, approx.) in Germany (2009): 0.00122, Consumption (g per capita) in the USA (2002): 0.00162, Calculated removal (%): 12.8, For the treatment of schizophrenia in adults and in adolescents, ages 13 to 17, and for the short-term treatment of manic or mixed episodes of bipolar I disorder in children and adolescents ages 10 to 17. May also be used to manage symptoms of inappropriate behavior due to aggression and, or psychosis in patients with severe dementia., Use Classification: Pharmaceuticals, Methods of Manufacturing: A Friedel-Crafts condensation of 1-acetylpiperidone-4-carbonyl chloride and 2, 4-difluorobenzene, followed by hydrolysis of the N-acetyl group yields 4-(2, 4-difluorobenzoyl)piperidone and the benzoyl carbonyl is converted to the oxime. With alkali, the fluorine atom in the 2-position is displaced through ring closure to form the isoxazole moiety. The secondary amine of the piperidine ring is alkylated with 3-(2-chloroethyl)pyridol[1, 2-a]pyrimidin-4-one to yield the product., Preparation: L. E. J. Kennis, J. Vandenberk, European Patent Office 196132, eidem, United States of America patent 4804663 (1986, 1989 both to Janssen), Impurities: 3-[2-[4-[(E)-(2, 4-difluorophenyl)(hydroxyimino)methyl]piperidin-1-yl]ethyl]-2-methyl-6, 7, 8, 9-tetrahydro-4H-pyrido[1, 2-a]pyrimidin-4-one, 3-[2-[4-[(Z)-(2, (9RS)-3-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6, 3-[2-[4-(5-fluoro-1, 2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6, (6RS)-3-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2, 6-dimethyl-6, 2-[2-methyl-4-oxo-6, 2-a]pyrimidin-3-yl]ethyl 4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperidine-1-carboxylate, 3-[2-[4-(2, 4-difluorobenzoyl)piperidin-1-yl]ethyl]-2-methyl-6, 3-[2-[4-[4-fluoro-2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperidine-1-yl]benzoyl]piperidin-1-yl]ethyl]-2-methyl-6, Formulations, Preparations: Table: Risperidone Preparations [Table#7275], Table: Risperidone Preparations [Table#7276].
Independent reference data for Risperidone (CAS 106266-06-2), compiled from public chemistry databases.
| CAS Registry Number | 106266-06-2 |
|---|---|
| PubChem CID | 5073 |
| Molecular formula | C23H27FN4O2 |
| IUPAC name | 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one |
| UNII (FDA) | L6UH7ZF8HC |
| Molecular Weight | 410.5 |
|---|---|
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 4 |
| Exact Mass | 410.21180428 |
| Monoisotopic Mass | 410.21180428 |
| Topological Polar Surface Area | 61.9 |
| Heavy Atom Count | 30 |
| Boiling Point | 442 |
|---|---|
| Melting Point | 170 |
| Melting Point | 170 °C |
| Solubility | 2.33 |
| LogP | 2.86 |
| Dissociation Constants | 8.3 |
| Collision Cross Section | 205.77 Ų [M+H]+ |
risperidone; 106266-06-2; Risperdal; Risperdal Consta; Rispolept; Rispolin; Risperin; Sequinan; Risperidona; Risperidal M-Tab; Risperidonum; Risperdal M-Tab; Spiron; Perseris; R 64 766; R-64766
| Reported hazard statements | H301 (99.3%), H331 (12.3%), H351 (12.3%), H411 (19.2%) |
|---|
H301 (99.3%): Toxic if swallowed [Danger Acute toxicity, oral]
H331 (12.3%): Toxic if inhaled [Danger Acute toxicity, inhalation]
Risperidone · CAS 106266-06-2 · C23H27FN4O2. UNII L6UH7ZF8HC. Boiling Point: 442; Melting Point: 170; Melting Point: 170 °C.
Source: PubChem / Wikidata; the batch COA governs where values differ.
Supplier: Jinan Shenghe Chemical Co., Ltd.
中文页面: 利培酮